News / Utah / 
FDA: 2 Utah facilities got non-tainted products from pharmacy tied to meningitis

FDA: 2 Utah facilities got non-tainted products from pharmacy tied to meningitis

By Shara Park and Dave Cawley | Posted - Oct. 23, 2012 at 7:29 a.m.



This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

SALT LAKE CITY — The Food and Drug Administration released a detailed list Monday of customers who received products from the pharmacy tied to a deadly meningitis outbreak. Two Utah facilities were on the list, but Tuesday morning it appears the FDA is revising the list.

The two facilities are the Cottonwood Surgery Center in Murray and the Zion Eye Institute in St. George. Neither facility received the tainted steroid injections tied to fungal meningitis, and there have been no reports of any contaminated drugs in Utah.

In fact, Jodi Jones, administrator over Cottonwood Surgery Center, said the last time the CSC received anything from the New England Compounding Center was last spring. It was a Mitomycin solution, which is used to irrigate the bladder, not the cardioplegic solution for the heart as initially reported.

Contact Information
Cottonwood Surgery Center
6053 Fashion Square Drive
Salt Lake City, UT 84107
801-262-0098

Zion Eye Institute
1791 East 280 North
St. George, UT 84790
435-656-2020

Jones said the solution is ordered on a case-by-case basis. The facility hasn't received any solutions from the New England Compounding Center since last spring, so they have nothing at their facility of concern.

Jones said the facility has no other products from NECC, but if patients still have questions they can call the facility.

According to the Utah Department of Health, the two Utah providers on the list did not get the tainted steroid already connected to the deadly meningitis outbreak. But they did receive other medications manufactured at the same location. They were advised to isolate and not dispense any medications on the list.

From the FDA website
NOTE: FDA has found some technical problems with the list and the data are incorrect. FDA is working to correct the list and will re-post when we are sure it is accurate.

Theron Jeppson, an epidemiologist with the Utah Department of Health, said there have been no complications reported in Utah related to the distributed drugs, but he said patients who received treatment at those facilities should be vigilant in watching for any side effects or symptoms. If patients have any concerns or questions they can call their doctor.

The Department of Justice has launched a criminal investigation involving the New England Compounding Center, where the drugs were made. The tainted drugs have put a total of 14,000 people at risk nationwide.

Related Stories

Shara Park
    Dave Cawley

      SIGN UP FOR THE KSL.COM NEWSLETTER

      Catch up on the top news and features from KSL.com, sent weekly.
      By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

      KSL Weather Forecast